
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
Zealand focuses intensively on holding a broad covering and very solid patent portfolio that ensures maximum protection of our products and core technologies. The strategy also involves seeking broad protection of specific products and their formulation. The ultimate goal is to ensure that Zealand Pharma and its collaborative partners avoid or are aware of patent challenges that could obstruct any of their projects.
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 27.7.2010